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Background: Proper triage of patients with acute chest pain (ACP) in the emergency department (ED) is critical for delivering cost-effective 
care. Stress myocardial perfusion imaging (MPI) is one such method for evaluating ACP patients who have a non-diagnostic electrocardiogram for 
ischemia. We examined the relative value of stress MPI versus exercise treadmill testing (ETT) based on US commercial and Medicare health plan 
claims data.
Methods: Retrospective study of adults admitted to the ED from 01/2007-12/2009 who had diagnostic testing with either MPI or ETT. All patients 
were followed for one year following the index test. Patients were stratified into low, medium, and high risk groups based on their history of coronary 
artery disease (CAD) and CAD-equivalent conditions. Patients were also matched using propensity scoring based on age, gender, geographic 
region, and history of hypertension, dyslipidemia, stroke, CAD and congestive heart failure. Outcomes included: 1) total follow-up health care costs, 
and 2) cardiac events defined as any subsequent hospitalization for CAD, coronary angiography, heart failure, myocardial infarction, or coronary 
revascularization and/or death.
Results: A total of 22,828 patients (11,414 ETT; 11,414 MPI) were included for analysis; mean age (± standard deviation) was 60 (±14) years 
and 48% were male. Cardiac event rates significantly higher at one year in ETT (15.0%) versus MPI (9%) patients (p<0.001). In addition, mean 
(± standard deviation) total health care costs were significantly higher in ETT ($27,047 ± $43,727) than in MPI patients ($19,603 ± $34,154, 
p<0.001). This was true across all 3 patient risk groups. Even patients defined as low risk had both a higher cardiac event rate (4.4% versus 3.4%, 
p<0.02) and associated costs ($17,347 versus $14,770; p<0.001) when evaluated with ETT versus MPI, respectively.
Conclusions: Evaluation of ACP patients in the ED with stress MPI resulted in a lower cardiac event rate and at lower cost as compared to ETT. In 
this real-world setting, stress MPI was superior to ETT, and irrespective of initial patient risk profile. Our results support stress MPI over ETT as a first 
line testing strategy in the ED evaluation of ACP.
